1. Home
  2. LODE vs OBIO Comparison

LODE vs OBIO Comparison

Compare LODE & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comstock Inc.

LODE

Comstock Inc.

HOLD

Current Price

$3.72

Market Cap

290.0M

Sector

Industrials

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$4.11

Market Cap

238.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LODE
OBIO
Founded
1999
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
290.0M
238.3M
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
LODE
OBIO
Price
$3.72
$4.11
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$4.00
$14.25
AVG Volume (30 Days)
1.7M
232.6K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
63.55
33.13
EPS
N/A
N/A
Revenue
$1,553,796.00
$33,482,000.00
Revenue This Year
$1,582.85
N/A
Revenue Next Year
$246.20
$12.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1169.22
52 Week Low
$2.24
$2.20
52 Week High
$4.80
$5.42

Technical Indicators

Market Signals
Indicator
LODE
OBIO
Relative Strength Index (RSI) 47.72 53.14
Support Level $3.48 $3.77
Resistance Level $3.75 $4.18
Average True Range (ATR) 0.27 0.17
MACD -0.05 0.02
Stochastic Oscillator 0.00 81.08

Price Performance

Historical Comparison
LODE
OBIO

About LODE Comstock Inc.

Comstock Inc commercializes technologies that convert underutilized waste and natural resources into clean energy and supporting products, including electrification, metals, and minerals from end-of-life solar panels. Its subsidiary focuses on producing renewable fuels from waste, energy crops, and woody biomass, supported by facilities in Wisconsin, pilot farms, a biorefinery site in Tulsa, and solar panel recycling operations in Nevada. The Company operates through two high-growth segments and a corporate segment, with its activities grouped into Metals, which generates the majority of revenue, Fuels, Mining, Strategic Investments, and Corporate Services.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: